Life is a balance. We help you to control what you can’t.


Thyroid subclinical disorders

The prevalence of subclinical hypo- and hyperthyroidism is about 4/8.5 percent and 2% respectively, but it incredibly increases in people older than 60 years.

While full-blown clinical disorders are treated with standardized therapy, the management of subclinical thyroid dysfunctions is controversial.



The current world epidemic of obesity represents a tremendous medical and public health challenge. A major consequence of obesity has been a rapid acceleration in the prevalence of type 2 diabetes that, combined with other triggering-inflammation conditions, define a dysmetabolic condition, an increasing but still underestimated and undertreated public problem.